{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:43:48Z","timestamp":1787010228898,"version":"build-2736575974"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Children with acute lymphoblastic leukemia (ALL) require central lines to facilitate their care. Peripherally inserted central catheters (PICCs) may have lower rates of central line-associated bloodstream infections (CLABSIs) versus other central lines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>The objective of this study was to compare the CLABSI rate in the first month of therapy after initiating a policy to place PICCs in new patients with severe neutropenia (SN) and Mediports in those with moderate-to-no neutropenia. We also examined thrombosis rates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design\/Method:<\/jats:title>\n                    <jats:p>We prospectively gathered data on new patients for 2.5 years following the policy change and retrospectively for the 2 years prior and compared rates of CLABSIs and thrombosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      CLABSIs decreased in SN patients from 7.52\/1000 to 3.11\/1000 line days (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.33). The CLABSI rate for all patients with SN who had a Mediport was 13.39\/1000 versus 4.08\/1000 line days for those that received PICCs (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.15). The thrombosis rate for Mediport patients was 3.13 clots\/1000 versus 7.65\/1000 line days for PICC patients, but the difference was not significant (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.11).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The differences observed suggest that placing PICCs versus Mediports in new ALL patients with SN may result in a lower incidence of CLABSIs in the first month of therapy without a significant increase in thrombosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mph.0000000000001748","type":"journal-article","created":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T03:33:31Z","timestamp":1581910411000},"page":"433-437","source":"Crossref","is-referenced-by-count":3,"title":["Instituting a New Central Line Policy to Decrease Central Line-associated Blood Stream Infection Rates During Induction Therapy in Pediatric Acute Lymphoblastic Leukemia Patients"],"prefix":"10.1097","volume":"42","author":[{"given":"Rebecca","family":"Berger","sequence":"first","affiliation":[{"name":"Cancer and Blood Disorders Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison F.","family":"Messina","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"Chandler","sequence":"additional","affiliation":[{"name":"Department of Surgery, Johns Hopkins All Children\u2019s Hospital, St. Petersburg, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest K.","family":"Amankwah","sequence":"additional","affiliation":[{"name":"Cancer and Blood Disorders Institute"},{"name":"Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H.","family":"Shaw","sequence":"additional","affiliation":[{"name":"Cancer and Blood Disorders Institute"},{"name":"Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,2,14]]},"reference":[{"key":"R1-20231002","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/00043426-199907000-00005","article-title":"Central venous catheter use and the risk of infection in children with acute lymphoblastic leukemia: a report from the Children\u2019s Cancer Group","volume":"21","author":"Rackoff","year":"1999","journal-title":"J Pediatr Hematol Oncol"},{"key":"R2-20231002","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.amjmed.2015.01.027","article-title":"Peripherally inserted central catheter\u2014associated deep vein thrombosis: a narrative review","volume":"128","author":"Fallouh","year":"2015","journal-title":"Am J Med"},{"key":"R3-20231002","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00134-010-2043-x","article-title":"Peripherally inserted central venous catheters and central venous catheters related thrombosis in post-critical patients","volume":"37","author":"Bonizzoli","year":"2011","journal-title":"Intensive Care Med"},{"key":"R4-20231002","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.ajic.2014.07.025","article-title":"Attributable costs of central line-associated bloodstream infections in a pediatric hematology\/oncology population","volume":"42","author":"Wilson","year":"2014","journal-title":"Am J Infect Control"},{"key":"R5-20231002","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/pbc.26194","article-title":"Health care institutional charges associated with ambulatory bloodstream infections in pediatric oncology and stem cell transplant patients","volume":"64","author":"Wong Quiles","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"R6-20231002","doi-asserted-by":"crossref","first-page":"e1678","DOI":"10.1542\/peds.2014-0582","article-title":"Children\u2019s Hospital Association Hematology\/Oncology CLABSI Collaborative. Preventing CLABSIs among pediatric hematology\/oncology inpatients: national collaborative results","volume":"134","author":"Bundy","year":"2014","journal-title":"Pediatrics"},{"key":"R7-20231002","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00134-017-4852-7","article-title":"Peripherally inserted central catheters are associated with lower risk of bloodstream infection compared with central venous catheters in paediatric intensive care patients: a propensity-adjusted analysis","volume":"43","author":"Yamaguchi","year":"2017","journal-title":"Intensive Care Med"},{"key":"R8-20231002","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/pbc.26053","article-title":"Central line associated blood stream infections in pediatric hematology\/oncology patients with different types of central lines","volume":"63","author":"Hord","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"R9-20231002","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1097\/MPH.0000000000000519","article-title":"Central venous catheters and bloodstream infection during induction therapy in children with acute lymphoblastic leukemia","volume":"38","author":"Bergmann","year":"2016","journal-title":"J Pediatr Hematol Oncol"},{"key":"R10-20231002","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00520-008-0561-7","article-title":"Infective and thrombotic complications of central venous catheters in patients with hematological malignancy: prospective evaluation of nontunneled devices","volume":"17","author":"Worth","year":"2009","journal-title":"Support Care Cancer"},{"key":"R11-20231002","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/pbc.10450","article-title":"Factors influencing central line infections in children with acute lymphoblastic leukemia: results of a single institutional study","volume":"42","author":"Abbas","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"R12-20231002","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1200\/JCO.2005.12.097","article-title":"Central venous lines in children with lesser risk acute lymphoblastic leukemia: optimal type and timing of placement","volume":"23","author":"McLean","year":"2005","journal-title":"J Clin Oncol"},{"key":"R13-20231002","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.jpedsurg.2010.02.077","article-title":"Exclusion of neutropenic children from implanted central venous catheter placement: impact on early catheter removal","volume":"45","author":"Gutierrez","year":"2010","journal-title":"J Pediatr Surg"},{"key":"R14-20231002","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1177\/000313480707301035","article-title":"Complications of implanted central venous catheters in neutropenic children","volume":"73","author":"Elihu","year":"2007","journal-title":"Am Surg"},{"key":"R15-20231002","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1097\/MPH.0b013e318290c24f","article-title":"Prospective surveillance study of blood stream infections associated with central venous access devices (port-type) in children with acute leukemia: an intervention program","volume":"35","author":"Berrueco","year":"2013","journal-title":"J Pediatr Hematol Oncol"},{"key":"R16-20231002","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1080\/08880018.2017.1319450","article-title":"Incidence and characteristics of venous thrombotic events in pediatric cancer patients: a 20-year experience in the Maritimes, Canada","volume":"34","author":"Asyyed","year":"2017","journal-title":"Pediatr Hematol Oncol"},{"key":"R17-20231002","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s00277-015-2481-1","article-title":"Recommendations for the use of long-term central venous catheter (CVC) in children with hemato-oncological disorders: management of CVC-related occlusion and CVC-related thrombosis. On behalf of the coagulation defects working group and the supportive therapy working group of the Italian Association of Pediatric Hematology and Oncology (AIEOP)","volume":"94","author":"Giordano","year":"2015","journal-title":"Ann Hematol"},{"key":"R18-20231002","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s00277-016-2798-4","article-title":"Incidence of catheter-related thrombosis in acute leukemia patients: a comparative, retrospective study of the safety of peripherally inserted vs. centrally inserted central venous catheters","volume":"95","author":"Refaei","year":"2016","journal-title":"Ann Hematol"},{"key":"R19-20231002","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.thromres.2017.07.002","article-title":"Epidemiology, diagnosis, prevention and treatment of catheter-related thrombosis in children and adults","volume":"157","author":"Baumann","year":"2017","journal-title":"Thromb Res"},{"key":"R20-20231002","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jvs.2011.10.005","article-title":"Peripherally inserted central catheter usage patterns and associated symptomatic upper extremity venous thrombosis","volume":"55","author":"Liem","year":"2012","journal-title":"J Vasc Surg"},{"key":"R21-20231002","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1177\/1129729818757970","article-title":"Peripherally inserted central catheters in the treatment of children with cancer: results of a multicenter study","volume":"19","author":"Rykov","year":"2018","journal-title":"J Vasc Access"},{"key":"R22-20231002","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.thromres.2018.10.013","article-title":"Comparative thrombosis risk of vascular access devices among critically ill medical patients","volume":"172","author":"White","year":"2018","journal-title":"Thromb Res"},{"issue":"suppl 1","key":"R23-20231002","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.thromres.2018.01.019","article-title":"Thrombosis in pediatric patients with leukemia","volume":"164","author":"Levy-Mendelovich","year":"2018","journal-title":"Thromb Res"},{"key":"R24-20231002","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1055\/s-0039-1679938","article-title":"PREVAPIX-ALL: apixaban compared to standard of care for prevention of venous thrombosis in paediatric acute lymphoblastic leukaemia (ALL)-rationale and design","volume":"119","author":"O\u2019Brien","year":"2019","journal-title":"Thromb Haemost"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000001748","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T15:23:42Z","timestamp":1696260222000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000001748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,14]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000001748","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2,14]]}}}